(Louis) Amplify CKLA, Unit 1, Reader (Large Print)
by American Printing House for the Blind
Last verified June 27, 2026 · classified July 1, 2026
What it is
Summary
AI-generated from vendor-published content · July 1, 2026
This is a large-print edition of the Amplify CKLA (Core Knowledge Language Arts) Unit 1 Reader, produced by the American Printing House for the Blind for students with low vision who use standard print curriculum in their classrooms. APH reformats commercial educational texts into accessible large-print versions so students don't have to work from standard-sized type that strains or excludes them. This is a single unit reader — just Unit 1 — so a student working through the full CKLA curriculum would need additional units as the year progresses. It's Federal Quota eligible, meaning qualifying students can be funded through their state's APH quota allocation rather than out of pocket, which is the most common funding path for this type of material.
Quick Facts Catalog facts · auto-generated
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
Open and read — no setup required. This is a print book in large-print format. - With professional help
A teacher of the visually impaired (TVI) or vision specialist confirms the appropriate print size and format for the student and orders through the school's Federal Quota account.
Getting it
Many states lend devices like this for free trial periods — find your state's AT lending program.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified June 27, 2026.
Classification & description AI-generated from vendor-published content on July 1, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.